These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16403604)

  • 1. Rheumatoid arthritis induced-fatty liver theory: one reason for global increase in prevalence of diabetes.
    Ahmed MH
    Med Hypotheses; 2006; 66(4):862-3. PubMed ID: 16403604
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.
    Stamatelopoulos KS; Kitas GD; Papamichael CM; Chryssohoou E; Kyrkou K; Georgiopoulos G; Protogerou A; Panoulas VF; Sandoo A; Tentolouris N; Mavrikakis M; Sfikakis PP
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1702-8. PubMed ID: 19608975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF; Diehl AM
    Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Tarantino G; Saldalamacchia G; Conca P; Arena A
    J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver: a novel component of the metabolic syndrome.
    Kotronen A; Yki-Järvinen H
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):27-38. PubMed ID: 17690317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts in the pathogenesis of nonalcoholic fatty liver disease.
    Méndez-Sánchez N; Arrese M; Zamora-Valdés D; Uribe M
    Liver Int; 2007 May; 27(4):423-33. PubMed ID: 17403181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and trends of insulin resistance, impaired fasting glucose, and diabetes.
    Ioannou GN; Bryson CL; Boyko EJ
    J Diabetes Complications; 2007; 21(6):363-70. PubMed ID: 17967708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
    Parekh S; Anania FA
    Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and liver disease: an ominous association.
    Moscatiello S; Manini R; Marchesini G
    Nutr Metab Cardiovasc Dis; 2007 Jan; 17(1):63-70. PubMed ID: 17164082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty liver in diabetes mellitus.
    J Tenn Med Assoc; 1981 Jul; 74(7):514-5. PubMed ID: 7278248
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes.
    Grønbaek H; Thomsen KL; Rungby J; Schmitz O; Vilstrup H
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):705-11. PubMed ID: 19072347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
    Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis and diabetes mellitus: evidence for an association?
    Doran M
    J Rheumatol; 2007 Mar; 34(3):460-2. PubMed ID: 17343298
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin resistance: cause or consequence of nonalcoholic steatohepatitis?
    Ahima RS
    Gastroenterology; 2007 Jan; 132(1):444-6. PubMed ID: 17241893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.